Hypertension, Systemic Inflammation and Body Weight in Relation to Lung Function Impairment—An Epidemiological Study

REFERENCES

• Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163(5)1256–1276
   PubMedGoogle Scholar
• Mannino D M, Buist A S. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet Sep 1, 2007; 370(9589)765–773, Review
   PubMed Web of Science ®Google Scholar
• Rutten F H, Cramer M J, Lammers J W, Grobbee D E, Hoes A W. Heart failure and chronic obstructive pulmonary disease: An ignored combination?. Eur J Heart Fail Nov, 2006; 8(7)706–711, Review
   PubMed Web of Science ®Google Scholar
• Rana J S, Mittleman M A, Sheikh J, Hu F B, Manson J E, Colditz G A, Speizer F E, Barr R G, Camargo C A, Jr. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care Oct, 2004; 27(10)2478–2484
   PubMed Web of Science ®Google Scholar
• Jørgensen N R, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med Mar, 2008; 14(2)122–127, Review
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Costi S, Luppi F, Cirelli G, Cilione C, Coletti O, Fabbri L M, Clini E M. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax Jun, 2008; 63(6)487–492
   PubMed Web of Science ®Google Scholar
• Enright P L, Kronmal R A, Smith V E, Gardin J M, Schenker M B, Manolio T A. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest 1995; 107(1)28–35
   PubMed Web of Science ®Google Scholar
• Engström G, Hedblad B, Valind S, Janzon L. Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function. J Hypertens Feb, 2001; 19(2)295–301
   PubMed Web of Science ®Google Scholar
• Wu Y, Vollmer W M, Buist A S, Tsai R, Cen R, Wu X, Chen P, Li Y, Guo C, Mai J, Davis C E. Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou. Int J Epidemiol Feb, 1998; 27(1)49–56
   PubMed Web of Science ®Google Scholar
• Wannamethee S G, Shaper A G, Ebrahim S. Respiratory function and risk of stroke. Stroke Nov, 1995; 26(11)2004–2010
   PubMed Web of Science ®Google Scholar
• Sin D D, Anthonisen N R, Soriano J B, Agusti A G. Mortality in COPD: Role of comorbidities. Eur Respir J Dec, 2006; 28(6)1245–1257, Review
   PubMed Web of Science ®Google Scholar
• Foschino Barbaro M P, Carpagnano G E, Spanevello A, Cagnazzo M G, Barnes P J. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol Oct–Dec, 2007; 20(4)753–763
   PubMed Web of Science ®Google Scholar
• Pepys M B, Hirschfield G M. C-reactive protein: A critical update. J Clin Invest 2003; 111(12)1805–1812
   PubMed Web of Science ®Google Scholar
• Jovicić S, Ignjatović S, Dajak M, Majkić-Singh N. Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay. Clin Chem Lab Med 2006; 44(2)228–231
   PubMed Web of Science ®Google Scholar
• Olafsdottir I S, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jögi R, Janson C. C-reactive protein levels are increased in non-allergic but not allergic asthma: A multicentre epidemiological study. Thorax Jun, 2005; 60(6)451–454
   PubMed Web of Science ®Google Scholar
• Broekhuizen R, Wouters E F, Creutzberg E C, Schols A M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax Jan, 2006; 61(1)17–22
   PubMed Web of Science ®Google Scholar
• Franciosi L G, Page C P, Celli B R, Cazzola M, Walker M J, Danhof M, Rabe K F, Della Pasqua O E. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2006; 19(3)189–199
   PubMed Web of Science ®Google Scholar
• Fabbri L M, Rabe K F. From COPD to chronic systemic inflammatory syndrome?. Lancet Sep 1, 2007; 370(9589)797–799
   PubMed Web of Science ®Google Scholar
• Buist A S, McBurnie M A, Vollmer W M, Gillespie S, Burney P, Mannino D M, Menezes A MB, Sullivan S D, Lee T A, Weiss K B, Jensen R L, Marks G B, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007; 370: 741–750
   PubMed Web of Science ®Google Scholar
• ECRH. European Community Respiratory Survey II. 2004, http://ecrhs.org/quest.com
   Google Scholar
• Lung Health Study Questionnaire, 2nd edition. 2004, http://bccrc.ca/download/ci/lc02_questionnaire.doc
   Google Scholar
• Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med Jan, 1999; 159(1)179–187
   PubMed Web of Science ®Google Scholar
• WHO. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health, OsloNorway, http://www.whocc.no/atcddd
   Google Scholar
• Schols A M, Slangen J, Volovics L, Wouters E F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med Jun, 1998; 157: 1791–1797, (6 Pt 1)
   PubMed Web of Science ®Google Scholar
• Peeters A, Barendregt J J, Willekens F, Mackenbach J P, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med Jan 7, 2003; 138(1)24–32
   PubMed Web of Science ®Google Scholar
• Fabbri L M, Luppi F, Beghé B, Rabe K F. Complex chronic comorbidities of COPD. Eur Respir J Jan, 2008; 31(1)204–212
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik C S, Brøndum E, Nieminen M M, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: The role of treatment and co-morbidity. Respir Res Aug 16, 2006; 7: 109
   PubMed Web of Science ®Google Scholar
• Fox C S, Massaro J M, Hoffmann U, Pou K M, Maurovich-Horvat P, Liu C Y, Vasan R S, Murabito J M, Meigs J B, Cupples L A, D'Agostino R B, Sr, O'Donnell C J. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation Jul 3, 2007; 116(1)39–48
   PubMed Web of Science ®Google Scholar
• Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes Apr, 2007; 56(4)901–911
   PubMed Web of Science ®Google Scholar
• Keddissi J I, Younis W G, Chbeir E A, Daher N N, Dernaika T A, Kinasewitz G T. The use of statins and lung function in current and former smokers. Chest Dec, 2007; 132(6)1764–1771
   PubMed Web of Science ®Google Scholar
• Søyseth V, Brekke P H, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J Feb, 2007; 29(2)279–283
   PubMed Web of Science ®Google Scholar
• van Gestel Y R, Hoeks S E, Sin D D, Simsek C, Welten G M, Schouten O, Stam H, Mertens F W, van Domburg R T, Poldermans D. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol Jul 15, 2008; 102(2)192–196
   PubMed Web of Science ®Google Scholar